These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24739665)

  • 1. Pharmacokinetic drug interaction between cyclosporine and imatinib in bone marrow transplant children and model-based reappraisal of imatinib drug interaction profile.
    Bleyzac N; Kebaili K; Mialou V; Bertrand Y; Goutelle S
    Ther Drug Monit; 2014 Dec; 36(6):724-9. PubMed ID: 24739665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of imatinib in Iranian patients with chronic-phase chronic myeloid leukemia.
    Golabchifar AA; Rezaee S; Ghavamzadeh A; Alimoghaddam K; Dinan NM; Rouini MR
    Cancer Chemother Pharmacol; 2014 Jul; 74(1):85-93. PubMed ID: 24817601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib.
    Atiq F; Broers AE; Andrews LM; Doorduijn JK; Koch BC; Van Gelder T; Versmissen J
    Eur J Clin Pharmacol; 2016 Jun; 72(6):719-23. PubMed ID: 26965514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levels.
    Gotta V; Widmer N; Montemurro M; Leyvraz S; Haouala A; Decosterd LA; Csajka C; Buclin T
    Clin Pharmacokinet; 2012 Mar; 51(3):187-201. PubMed ID: 22339450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronidazole leads to enhanced uptake of imatinib in brain, liver and kidney without affecting its plasma pharmacokinetics in mice.
    Tan SY; Kan E; Lim WY; Chay G; Law JH; Soo GW; Bukhari NI; Segarra I
    J Pharm Pharmacol; 2011 Jul; 63(7):918-25. PubMed ID: 21635257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoinhibition of CYP3A4 leads to important role of CYP2C8 in imatinib metabolism: variability in CYP2C8 activity may alter plasma concentrations and response.
    Filppula AM; Neuvonen M; Laitila J; Neuvonen PJ; Backman JT
    Drug Metab Dispos; 2013 Jan; 41(1):50-9. PubMed ID: 23028140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib plasma levels during successful long-term treatment of metastatic-gastrointestinal stromal tumors.
    Sawaki A; Inaba K; Nomura S; Kanie H; Yamada T; Hayashi K; Okawaki M; Yamamura M; Yamaguchi Y; Hirai T; Orito E
    Hepatogastroenterology; 2014 Oct; 61(135):1984-9. PubMed ID: 25713899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kinetic deuterium isotope effect as applied to metabolic deactivation of imatinib to the des-methyl metabolite, CGP74588.
    Manley PW; Blasco F; Mestan J; Aichholz R
    Bioorg Med Chem; 2013 Jun; 21(11):3231-9. PubMed ID: 23611771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
    Menon-Andersen D; Mondick JT; Jayaraman B; Thompson PA; Blaney SM; Bernstein M; Bond M; Champagne M; Fossler MJ; Barrett JS
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours.
    Haouala A; Widmer N; Guidi M; Montemurro M; Leyvraz S; Buclin T; Eap CB; Decosterd LA; Csajka C
    Br J Clin Pharmacol; 2013 Apr; 75(4):1007-18. PubMed ID: 22891806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long-term prospective population pharmacokinetic study on imatinib plasma concentrations in GIST patients.
    Eechoute K; Fransson MN; Reyners AK; de Jong FA; Sparreboom A; van der Graaf WT; Friberg LE; Schiavon G; Wiemer EA; Verweij J; Loos WJ; Mathijssen RH; De Giorgi U
    Clin Cancer Res; 2012 Oct; 18(20):5780-7. PubMed ID: 22850565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of imatinib mesilate on the disposition kinetics of ciclosporin in rats.
    Kajita T; Higashi Y; Imamura M; Maida C; Fujii Y; Yamamoto I; Miyamoto E
    J Pharm Pharmacol; 2006 Jul; 58(7):997-1000. PubMed ID: 16805961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and intracellular imatinib concentrations in patients with chronic myeloid leukemia.
    De Francia S; DʼAvolio A; Ariaudo A; Pirro E; Piccione F; Simiele M; Fava C; Calcagno A; Di Perri G; Saglio G
    Ther Drug Monit; 2014 Jun; 36(3):410-2. PubMed ID: 24342895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers.
    Hulskotte E; Gupta S; Xuan F; van Zutven M; O'Mara E; Feng HP; Wagner J; Butterton J
    Hepatology; 2012 Nov; 56(5):1622-30. PubMed ID: 22576324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Cheng Z; Zhao L; Chen G; Wu D; Qiu H; Tang X; Fu C; Jin Z; Chen F; Xue S; Sun A
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):114-9. PubMed ID: 24606651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of St John's wort on imatinib mesylate pharmacokinetics.
    Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
    Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of limited sampling strategies for estimation of cyclosporine area under the concentration-time curve in hematopoietic stem cell transplant patients.
    Hadjibabaie M; Vazirian I; Iravani M; Moosavi SA; Alimoghaddam K; Ghavamzadeh A; Rezaee S
    Ther Drug Monit; 2011 Dec; 33(6):673-80. PubMed ID: 22011723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
    Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR
    Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic drug-drug interaction of calcium channel blockers with cyclosporine in hematopoietic stem cell transplant children.
    Bernard E; Goutelle S; Bertrand Y; Bleyzac N
    Ann Pharmacother; 2014 Dec; 48(12):1580-4. PubMed ID: 25280976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditions.
    Gotta V; Bouchet S; Widmer N; Schuld P; Decosterd LA; Buclin T; Mahon FX; Csajka C; Molimard M
    Leuk Res; 2014 Jul; 38(7):764-72. PubMed ID: 24844604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.